Sudhish Sharma

CoapTech, Inc. develops medical devices. The company was founded by Steven Tropello and Howard Carolan and is headquartered in Baltimore, MD.

Sonavex, Inc. engages in the provision of medical device services. It has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs. The company was founded in 2013 and is headquartered in Baltimore, MD.

Harpoon Medical, Inc. develops surgical services. It offers an image-guided, minimally invasive surgical tool for mitral valve repair that enables surgeons to access and repair the mitral valve in a beating heart via a small incision between the ribs without the need for cardiac arrest or cardiopulmonary bypass. The company was founded by James S. Gammie and Peter Wilson in July 2013 and is headquartered in Baltimore, MD.

National Sleep Technologies, Inc. provides sleep diagnostic testing services in United States. The company's products are used to record brain movements during the patient's time at the center. The company is located in Arnold, MD.

Bello Machre, founded in 1972, is a not-for-profit agency that provides loving care, homes, and support to hundreds of individuals and families within the community. The agency employs over 300 skilled people and manages 54 homes in Anne Arundel County and one in Carroll County. Bello Machre serves children and adults with developmental disabilities, without regard to race, religion, gender, or national origin.

Mediq Prn Hne LLC provides healthcare products and services. The private company is based in Pennsauken, NJ and has subsidiaries in the United States.

Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX.

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies

ReGelTec, Inc. operates as a development stage medical device company. The firm develops minimally invasive spinal implants for lower back pain and degenerative disc disease. It commercializes HYDRAFIL, a percutaneous treatment for low back pain due to degenerative disc disease. The company was founded by Anthony M. Lowman and is headquartered in Baltimore, MD.